Emirates Drug Establishment meets with pharmaceutical industry

Emirates Drug Establishment meets with pharmaceutical industry

The new Emirates Drug Establishment (EDE), which was established in December 2023 to oversee the regulation of all medical and pharmaceutical products in the UAE, held an introductory meeting with more than 40 of the nation’s leading manufacturers and suppliers of healthcare products and services. The meeting was designed to introduce the role of the EDE, outline the support and assistance it can provide, and hear from the industry’s stakeholders on supporting the development of the UAE’s rapidly expanding healthcare sector. The Emirates Drug Establishment is tasked with regulating the production and distribution of all medical products across the UAE, including pharmaceuticals, medical devices, healthcare products, nutritional supplements and cosmetics. Its primary objective is to increase the UAE’s self-sufficiency and drug security by enhancing the country’s ability to produce, develop and manufacture high-quality medical and pharmaceutical products by facilitating research and development and providing a welcoming environment for investments in the sector. The meeting was attended by representatives of the leading names from the local and international pharmaceutical industry, including Abbott, AbbVie, Sanofi, MSD, Merck, AstraZeneca, Bayer, Bristol Myers Squibb, Kyowa Kirin, Leo Pharma, Eli Lilly, Novartis, Novo Nordisk, and Pfizer, who were joined by representatives of the main private